ロード中...
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and SARS-CoV-2 infection (causing coronavirus disease 2019 [COVID-19]) are serious diseases. To date, no effective post-exposure prophylaxis, prevention, or therapeutic agents are recommended as effective for these di...
保存先:
| 出版年: | Infectious Diseases & Immunity |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057313/ https://ncbi.nlm.nih.gov/pubmed/38630075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.ID9.0000733568.58627.47 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|